- Acquired by First Person Ltd., Jan 2025
- Raised Reverse Merger, Jan 2025
- Raised Follow-on PO, Jan 2018
About
Qrons Inc. is a biotechnology company dedicated to developing biotech products, treatments, and technologies to combat neuronal and infectious diseases, with a focus on antibiotic-resistant bacteria. Their approach leverages advances in artificial intelligence (AI), machine learning (ML), molecular biology, stem cells, and tissue engineering. The company has two product candidates for treating traumatic brain injuries: QS100, an injury-specific, 3D-printable, implantable MSC-synthetic hydrogel for penetrating brain injuries, and QS200, an injectable MSC-synthetic hydrogel for concussions. Qrons conducts its research in Israel under service agreements with Ariel University and has a sponsored research agreement with Dartmouth College. As of January 27, 2025, Qrons Inc. was acquired by First Person Ltd. in a reverse merger transaction. The combined company operates under the First Person brand, focusing on cognitive wellness and functional beverages.
Funding history · 3 rounds · — total
Headcount over time
Q&A
- What is Qrons' primary focus?
- Qrons is a biotechnology company focused on developing advanced stem-cell-based solutions for neuronal injuries and combating neuronal diseases.
- What product candidates is Qrons developing for traumatic brain injuries?
- Qrons has two product candidates: QS100, an injury-specific, 3D-printable, implantable MSC-synthetic hydrogel for penetrating brain injuries, and QS200, an injectable MSC-synthetic hydrogel for concussions.
- Where does Qrons conduct its research?
- Qrons conducts its research in Israel under service agreements with Ariel University and has an ongoing sponsored research agreement with Dartmouth College.
- When was Qrons founded?
- Qrons was founded in January 2016.
- What is Qrons' current employee count?
- Qrons has 4 employees, falling within the 1-10 employee bucket.
- What is Qrons' current market capitalization?
- Qrons' market capitalization is $199,800 USD.
- What is Qrons' total funding raised to date?
- Qrons has raised a total of $500,000 USD.
- What is Qrons' current public status?
- Qrons became public on OTC in August 2017.
- Who are the co-founders of Qrons?
- The co-founders of Qrons are Jonah Meer, who serves as CEO, CFO, and Director, and Ido Merfeld, who serves as President and Director.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | qrons.com/ |
|---|---|
| linkedin.com/company/37398497 |
Identifiers & details
| Legal name | Qrons Inc. |
|---|---|
| Former names | BioLabMart |
| Founded | 2016-8 |
| Employees (exact) | 1 |
| Offices | Queens |
| Market cap | $200K |
| Status reason | Public on OTC on Aug, 2017; |
Acquisitions & public offerings
Acquired by First Person Ltd. 2025-01
Radar intelligence
Patents
| EPO | 2 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | qrons.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|